The US Food and Drug Administration said on Tuesday that it has approved Berlex Laboratories Inc.’s Finacea (azelaic acid) gel, 15%, for topical treatment of inflammatory papules and pustules of mild to moderate rosacea.
The product will be sold by prescription. Another Berlex azelaic acid product — Finevin, a 20% formulation — was approved in the US last year to treat mild to moderate inflammatory acne. (See Reuters Health report, May 3, 2001.)
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!